RE:RE:RE:THTX’s short volume Don't expect what is impossible out of this presentation. The only new positive data they could bring is that the maximum tolerable dose is still not reached and that they are now over the MTD of free docetexel. They could also have pharmacokinetics data up to noe suggesting that the PDC is behaving the expected way. It would come through testing os free docetaxel in the blood over time after injection and the same for TH1902. Other than that, I don't see what new data on humans they could bring. That being said, maybe I am missing something. What is very unlikely, is some negative news concerning the trial. Why organizing such a presentation if it would be to disclose negative news? It does not make sense.
Lee430 wrote: Gonna be a long weekend waiting for the webinar or Great Rebrand, Pleeeease don't be another non event.
scarlet1967 wrote: Today about 170 k was traded in Nasdaq, the highest daily volume this week, short volum was 10.5% an increase from yesterday but far less than the median average. So most of the trades were buyers taking positions before Monday's webinar and sellers offloading as the price/volume increased to about monthly high.
Not enough price appreciation or volume to suspect a leak of information. It's everyone's guess what will be shared on Monday.
scarlet1967 wrote: Today over 90k was traded in Nasdaq which was the highest daily volume this week, the short volume was 5.56% which was one of the lowest this week so maybe some started to take positions already prior to Monday's webinar?
Also some pathetic after hours trading, only some 30 shares the latest trade to push the price down a little. Not as much volume as one would like to see prior to the event but better than previous trading days this week.
| Time (ET) | After Hours Price | After Hours Share Volume |
| 19:22:53 | $3.54 | 6 |
| 19:22:53 | $3.55 | 24 |
| 16:08:55 | $3.6 | 7 |